![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 31
Zeitschriftenartikel
Khouja, Mouhamad 
ORCID: https://orcid.org/0000-0002-9892-9461; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Pal, Karol ORCID: https://orcid.org/0000-0002-7726-4691; Stewart, Peter James; Regmi, Binaya ORCID: https://orcid.org/0009-0003-2663-0983; Schwarz, Martin; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Alig, Stefan K. ORCID: https://orcid.org/0000-0001-6825-702X; Darzentas, Nikos; Kluin-Nelemans, Hanneke C.; Hermine, Olivier; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Gonzalez de Castro, David ORCID: https://orcid.org/0000-0003-0580-5636; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340
(2024):
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials.
In: Leukemia, Bd. 38, Nr. 12: S. 2675-2684
[PDF, 3MB]
ORCID: https://orcid.org/0000-0002-9892-9461; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Pal, Karol ORCID: https://orcid.org/0000-0002-7726-4691; Stewart, Peter James; Regmi, Binaya ORCID: https://orcid.org/0009-0003-2663-0983; Schwarz, Martin; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Alig, Stefan K. ORCID: https://orcid.org/0000-0001-6825-702X; Darzentas, Nikos; Kluin-Nelemans, Hanneke C.; Hermine, Olivier; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Gonzalez de Castro, David ORCID: https://orcid.org/0000-0003-0580-5636; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340
(2024):
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials.
In: Leukemia, Bd. 38, Nr. 12: S. 2675-2684
[PDF, 3MB]
Fischer, Luca ORCID: https://orcid.org/0000-0003-2444-416X; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Schmidt, Christian; Stilgenbauer, Stephan ORCID: https://orcid.org/0000-0002-6830-9296; Bouabdallah, Krimo; Solal-Celigny, Philippe; Scholz, Christian W.; Feugier, Pierre; Wit, Maike de; Trappe, Ralf Ulrich; Hallek, Michael; Graeven, Ullrich ORCID: https://orcid.org/0000-0001-6082-7710; Hänel, Mathias; Hoffmann, Martin; Delwail, Vincent; Macro, Margaret; Greiner, Jochen ORCID: https://orcid.org/0000-0003-1256-173X; Giagounidis, Aristoteles A. N.; Dargel, Beate; Durot, Eric ORCID: https://orcid.org/0000-0003-3463-0089; Foussard, Charles; Silkenstedt, Elisabeth; Weigert, Oliver ORCID: https://orcid.org/0000-0002-0987-7373; Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Ribrag, Vincent und Dreyling, Martin
(2024):
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network.
In: Leukemia, Bd. 38: S. 1307-1314
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-2444-416X; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Schmidt, Christian; Stilgenbauer, Stephan ORCID: https://orcid.org/0000-0002-6830-9296; Bouabdallah, Krimo; Solal-Celigny, Philippe; Scholz, Christian W.; Feugier, Pierre; Wit, Maike de; Trappe, Ralf Ulrich; Hallek, Michael; Graeven, Ullrich ORCID: https://orcid.org/0000-0001-6082-7710; Hänel, Mathias; Hoffmann, Martin; Delwail, Vincent; Macro, Margaret; Greiner, Jochen ORCID: https://orcid.org/0000-0003-1256-173X; Giagounidis, Aristoteles A. N.; Dargel, Beate; Durot, Eric ORCID: https://orcid.org/0000-0003-3463-0089; Foussard, Charles; Silkenstedt, Elisabeth; Weigert, Oliver ORCID: https://orcid.org/0000-0002-0987-7373; Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Ribrag, Vincent und Dreyling, Martin
(2024):
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma—a randomized, open-label phase III trial of the European mantle cell lymphoma network.
In: Leukemia, Bd. 38: S. 1307-1314
[PDF, 1MB]
Dreyling, Martin; Doorduijn, Jeanette; Giné, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; Gomes da Silva, Maria; Leppä, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron D; Celli, Melania; Hess, Georg; Arcaini, Luca; Visco, Carlo; Meerten, Tom van; Wirths, Stefan; Zinzani, Pier Luigi; Novak, Urban; Herhaus, Peter; Benedetti, Fabio; Sonnevi, Kristina; Hanoun, Christine; Hänel, Matthias; Dierlamm, Judith; Pott, Christiane; Klapper, Wolfram; Gözel, Döndü; Schmidt, Christian; Unterhalt, Michael; Ladetto, Marco und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2024):
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
In: Lancet, Bd. 403, Nr. 10441: S. 2293-2306
ORCID: https://orcid.org/0000-0002-0749-1389
(2024):
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
In: Lancet, Bd. 403, Nr. 10441: S. 2293-2306
Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Delfau-Larue, Marie-Hélène ORCID: https://orcid.org/0000-0002-8010-2343; Macintyre, Elizabeth; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Tilly, Hervé ORCID: https://orcid.org/0000-0001-7022-5246; Wirths, Stefan ORCID: https://orcid.org/0000-0003-2494-9862; Feugier, Pierre; Hübel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C. ORCID: https://orcid.org/0000-0003-2617-9427; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249 und Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340
(2023):
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma. Results From the European Mantle Cell Lymphoma Elderly Trial.
In: Journal of Clinical Oncology, Bd. 42, Nr. 5: S. 538-549
ORCID: https://orcid.org/0000-0002-0749-1389; Delfau-Larue, Marie-Hélène ORCID: https://orcid.org/0000-0002-8010-2343; Macintyre, Elizabeth; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Tilly, Hervé ORCID: https://orcid.org/0000-0001-7022-5246; Wirths, Stefan ORCID: https://orcid.org/0000-0003-2494-9862; Feugier, Pierre; Hübel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C. ORCID: https://orcid.org/0000-0003-2617-9427; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249 und Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340
(2023):
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma. Results From the European Mantle Cell Lymphoma Elderly Trial.
In: Journal of Clinical Oncology, Bd. 42, Nr. 5: S. 538-549
Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Jurinovic, Vindi; Trotman, Judith ORCID: https://orcid.org/0000-0001-8009-4593; Kehden, Britta; Unterhalt, Michael; Herold, Michael ORCID: https://orcid.org/0000-0002-6801-3292; Jagt, Richard van der ORCID: https://orcid.org/0000-0001-5706-0109; Janssens, Ann; Kneba, Michael; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Young, Moya; Schmidt, Christian; Knapp, Andrea; Nielsen, Tina; Brown, Helen ORCID: https://orcid.org/0009-0007-3637-891X; Spielewoy, Nathalie; Harbron, Chris; Bottos, Alessia; Mundt, Kirsten; Marcus, Robert; Hiddemann, Wolfgang und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma. A Prospective Analysis of the Phase III GALLIUM Study.
In: Journal of Clinical Oncology
[PDF, 794kB]
ORCID: https://orcid.org/0009-0005-9260-8340; Jurinovic, Vindi; Trotman, Judith ORCID: https://orcid.org/0000-0001-8009-4593; Kehden, Britta; Unterhalt, Michael; Herold, Michael ORCID: https://orcid.org/0000-0002-6801-3292; Jagt, Richard van der ORCID: https://orcid.org/0000-0001-5706-0109; Janssens, Ann; Kneba, Michael; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Young, Moya; Schmidt, Christian; Knapp, Andrea; Nielsen, Tina; Brown, Helen ORCID: https://orcid.org/0009-0007-3637-891X; Spielewoy, Nathalie; Harbron, Chris; Bottos, Alessia; Mundt, Kirsten; Marcus, Robert; Hiddemann, Wolfgang und Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389
(2023):
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma. A Prospective Analysis of the Phase III GALLIUM Study.
In: Journal of Clinical Oncology
[PDF, 794kB]
Stathis, Anastasios; Mey, Ulrich; Schar, Sami; Hitz, Felicitas; Pott, Christiane; Mach, Nicolas; Krasniqi, Fatime; Novak, Urban; Schmidt, Christian; Hohloch, Karin; Kienle, Dirk Lars; Hess, Dagmar; Moccia, Alden A.; Unterhalt, Michael; Eckhardt, Katrin; Hayoz, Stefanie; Forestieri, Gabriela; Rossi, Davide; Dirnhofer, Stefan; Ceriani, Luca; Sartori, Giulio; Bertoni, Francesco; Buske, Christian; Zucca, Emanuele und Hiddemann, Wolfgang
(2022):
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma.
In: Blood Advances, Bd. 6, Nr. 13: S. 3911-3920
Hess, Georg; Huettmann, Andreas; Witzens-Harig, Mathias; Dreyling, Martin H.; Keller, Ulrich; Marks, Reinhard; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Frontzek, Fabian; Trautmann, Marcel; Ruckes, Christian; Deuster, Oliver; Rosenwald, Andreas; Theobald, Matthias und Lenz, Georg
(2022):
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
In: British Journal of Haematology, Bd. 198, Nr. 3: S. 482-491
Zimmermann, Heiner; Koenecke, Christian; Dreyling, Martin H.; Pott, Christiane; Duehrsen, Ulrich; Hahn, Dennis; Meidenbauer, Norbert; Hauser, Ingeborg A.; Rummel, Mathias J.; Wolf, Dominik; Heuser, Michael; Schmidt, Christian; Schlattmann, Peter; Ritgen, Matthias; Siebert, Reiner; Oschlies, Ilske; Anagnostopoulos, Ioannis und Trappe, Ralf U.
(2022):
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
In: Leukemia, Bd. 36, Nr. 10: S. 2468-2478
Dreyling, Martin; Andre, Marc; Gökbuget, Nicola; Tilly, Herve; Jerkeman, Mats; Gribben, John; Ferreri, Andres; Morel, Pierre; Stilgenbauer, Stephan; Fox, Christopher; Ribera, Jose Maria; Zweegman, Sonja; Aurer, Igor; Bödür, Csaba; Burkhardt, Birgit; Buske, Christian; Caballero, MariaDollores; Campo, Elias; Chapuy, Björn; Davies, Andrew; Leval, Laurence de; Doorduijn, Jeanette; Federico, Massimo; Gaulard, Philippe; Gay, Francesca; Ghia, Paolo; Gronbaek, Kirsten; Goldschmidt, Hartmut; Kersten, Marie-Jose; Kiesewetter, Barbara; Landman-Parker, Judith; Le Gouill, Steven; Lenz, Georg; Leppä, Sirpa; Lopez-Guillermo, Armando; Macintyre, Elizabeth; Mateos Mantega, Maria Victoria; Moreau, Philippe; Moreno, Carol; Nadel, Bertrand; Okosun, Jessica; Owen, Roger; Pospisilova, Sarka; Pott, Christiane; Robak, Tadeusz; Spina, Michelle; Stamatopoulos, Kostas; Stary, Jan; Tarte, Karin; Tedeschi, Allessandra; Thieblemont, Catherine; Trappe, Ralf Ulrich; Trümper, Lorenz H. und Salles, Gilles
(2022):
The EHA Research Roadmap: Malignant Lymphoid Diseases.
In: Hemasphere, Bd. 6, Nr. 6
[PDF, 2MB]
Hermine, Olivier ORCID: https://orcid.org/0000-0003-2574-3874; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Walewski, Jan ORCID: https://orcid.org/0000-0003-4247-2674; Bosly, André; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Szymczyk, Michal; Pott, Christiane; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Feugier, Pierre; Hübel, Kai; Haioun, Corinne; Casasnovas, René Olivier ORCID: https://orcid.org/0000-0002-1156-8983; Schmidt, Christian; Bouabdallah, Kamal; Ribrag, Vincent; Kanz, Lothar; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Metzner, Bernd; Sibon, David ORCID: https://orcid.org/0000-0002-9205-625X; Cheminant, Morgane; Burroni, Barbara; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2022):
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma. Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
In: Journal of Clinical Oncology, Bd. 41, Nr. 3: S. 479-484
ORCID: https://orcid.org/0000-0003-2574-3874; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Walewski, Jan ORCID: https://orcid.org/0000-0003-4247-2674; Bosly, André; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Szymczyk, Michal; Pott, Christiane; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Feugier, Pierre; Hübel, Kai; Haioun, Corinne; Casasnovas, René Olivier ORCID: https://orcid.org/0000-0002-1156-8983; Schmidt, Christian; Bouabdallah, Kamal; Ribrag, Vincent; Kanz, Lothar; Dürig, Jan ORCID: https://orcid.org/0000-0002-7672-3905; Metzner, Bernd; Sibon, David ORCID: https://orcid.org/0000-0002-9205-625X; Cheminant, Morgane; Burroni, Barbara; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389 und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2022):
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma. Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network.
In: Journal of Clinical Oncology, Bd. 41, Nr. 3: S. 479-484
Thurner, Lorenz; Fadle, Natalie; Bittenbring, Joerg Thomas; Regitz, Evi; Schuck, Rita; Cetin, Onur; Stuhr, Ariane; Rixecker, Torben; Murawski, Niels; Poeschel, Viola; Kaddu-Mulindwa, Dominic; Preuss, Klaus-Dieter; Stilgenbauer, Stephan; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Hartmann, Sylvia; Dreyling, Martin; Pott, Christiane; Bewarder, Moritz und Hoster, Eva
(2021):
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome.
In: Blood, Bd. 137, Nr. 23: S. 3251-3258
Thurner, Lorenz; Fadle, Natalie; Bittenbring, Jörg Thomas; Regitz, Evi; Schuck, Rita; Cetin, Onur; Stuhr, Arianne; Rixecker, Torben; Murawski, Niels M.; Poeschel, Viola; Kaddu-Mulindwa, Dominic; Preuss, Klaus Dieter; Stilgenbauer, Stephan; Hermine, Olivier; Kluin-Nelemans, Jc C.; Hartmann, Sylvia; Dreyling, Martin; Pott, Christiane; Bewarder, Moritz und Hoster, Eva
(2021):
LRPAP1-autoantibodies in mantle cell lymphoma are associated with superior outcome.
In: Blood, Bd. 137, Nr. 23: S. 3251-3258
Alig, Stefan; Jurinovic, Vindi; Esfahani, Mohammad Shahrokh; Haebe, Sarah; Passerini, Verena; Hellmuth, Johannes C.; Gaitzsch, Erik; Keay, William; Tahiri, Natyra; Zoellner, Anna-Katharina; Rosenwald, Andreas; Klapper, Wolfram; Stein, Harald; Feller, Alfred C.; Ott, German; Staiger, Annette M.; Horn, Heike; Hansmann, Martin-Leo; Pott, Christiane; Unterhalt, Michael; Schmidt, Christian; Dreyling, Martin; Alizadeh, Ash A.; Hiddemann, Wolfgang; Hoster, Eva und Weigert, Oliver
(22. September 2020):
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models.
In: Blood Advances, Bd. 4, Nr. 18: S. 4451-4462
Pott, Christiane; Sehn, Laurie H.; Belada, David; Gribben, John; Hoster, Eva; Kahl, Brad; Kehden, Britta; Nicolas-Virelizier, Emmanuelle; Spielewoy, Nathalie; Fingerle-Rowson, Guenter; Harbron, Chris; Mundt, Kirsten; Wassner-Fritsch, Elisabeth und Cheson, Bruce D.
(Februar 2020):
MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial.
In: Leukemia, Bd. 34, Nr. 2: S. 522-32
Roider, Tobias; Wang, Xi; Hüttl, Katrin; Dreger, Peter; Hermine, Olivier; Kluin-Nelemans, Hanneke C.; Grabe, Niels; Dreyling, Martin; Pott, Christiane; Ott, German; Hoster, Eva und Dietrich, Sascha
(2020):
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
In: International Journal of Cancer
Drandi, Daniela; Alcantara, Marion; Benmaad, Ichrafe; Soehlbrandt, Arian; Lhermitte, Ludovic; Zaccaria, GianMaria; Ferrante, Martina; Genuardi, Elisa; Mantoan, Barbara; Villarese, Patrick; Cheminant, Morgane; della Starza, Irene; Ciabatti, Elena; Bomben, Riccardo; Jimenez, Cristina; Callanan, Mary; Abdo, Chrystelle; Eckert, Cornelia; Ribrag, Vincent; Cortelazzo, Sergio; Dreyling, Martin; Hermine, Olivier; Delfau-Larue, Marie-Helene; Pott, Christiane; Ladetto, Marco; Ferrero, Simone und Macintyre, Elizabeth
(2020):
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network.
In: Hemasphere, Bd. 4, Nr. 2, e347
Kluin-Nelemans, Hanneke C.; Hoster, Eva; Hermine, Olivier; Walewski, Jan; Geisler, Christian H.; Trneny, Marek; Stilgenbauer, Stephan; Kaiser, Florian; Doorduijn, Jeanette K.; Salles, Gilles; Szymczyk, Michal; Tilly, Herve; Ribrag, Vincent; Klapper, Wolfram; Pott, Christiane; Unterhalt, Michael; Dreyling, Martin; Kanz, Lothar; Schmidt, Christian; Feugier, Pierre; Thieblemont, Catherine und Zijlstra, Josee M.
(2020):
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial.
In: Journal of Clinical Oncology, Bd. 38, Nr. 3: S. 248-256
König, Laila; Dreyling, Martin; Duerig, Jan; Engelhard, Marianne; Hohloch, Karin; Viardot, Andreas; Witzens-Harig, Mathias; Kieser, Meinhard; Klapper, Wolfram; Pott, Christiane und Herfarth, Klaus
(2019):
Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro)-GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial.
In: Trials, Bd. 20, Nr. 1, 544
Tam, Constantine S.; Anderson, Mary Ann; Pott, Christiane; Agarwal, Rishu; Handunnetti, Sasanka; Hicks, Rodney J.; Burbury, Kate; Turner, Gillian; Di Iulio, Juliana; Bressel, Mathias; Westerman, David; Lade, Stephen; Dreyling, Martin; Dawson, Sarah-Jane; Dawson, Mark A.; Seymour, John F. und Roberts, Andrew W.
(2018):
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.
In: New England Journal of Medicine, Bd. 378, Nr. 13: S. 1211-1223
Hoster, Eva und Pott, Christiane
(2016):
Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment.
In: Hematology. American Society of Hematology. Education Program, Bd. 2016, Nr. 1: S. 437-445
Hermine, Olivier; Hoster, Eva; Walewski, J.; Bosly, A.; Stilgenbauer, S.; Thieblemont, C.; Szymczyk, Michal; Bouabdallah, R.; Kneba, M.; Hallek, M.; Salles, G.; Feugier, P.; Ribrag, Vincent; Birkmann, J.; Forstpointner, R.; Haioun, C.; Hänel, M.; Casasnovas, R. O.; Finke, J.; Peter, N.; Bouabdallah, K.; Sebban, C.; Fischer, T.; Dührsen, U.; Metzner, B.; Maschmeyer, G.; Kanz, L.; Schmidt, C.; Delarue, R.; Brousse, N.; Klapper, Wolfram; Macintyre, E.; Delfau-Larue, M. H.; Pott, Christiane; Hiddemann, Wolfgang; Unterhalt, Michael und Dreyling, Martin
(2016):
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
In: Lancet, Bd. 388, Nr. 10044: S. 565-575
Wehkamp, Ulrike; Pott, Christiane; Unterhalt, Michael; Koch, Karoline; Weichenthal, Michael; Klapper, Wolfram und Oschlies, Ilske
(2015):
Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
In: American Journal of Surgical Pathology, Bd. 39, Nr. 8: S. 1093-1101
[PDF, 914kB]
Hoster, Eva; Geisler, C. H.; Doorduijn, J.; van der Holt, B.; Walewski, J.; Bloehdorn, J.; Ribrag, Vincent; Salles, G.; Hallek, M.; Pott, Christiane; Szymczyk, Michal; Kolstad, A.; Laurell, A.; Raty, R.; Jerkeman, M.; Van’t Veer, M.; Kluin-Nelemans, J. C.; Klapper, Wolfram; Unterhalt, Michael; Dreyling, Martin und Hermine, Olivier
(2015):
Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.
In: Leukemia, Bd. 30, Nr. 6: S. 1428-1430
Delfau-Larue, M. H.; Klapper, Wolfram; Berger, F.; Jardin, F.; Briere, J.; Salles, G.; Casasnovas, O.; Feugier, P.; Haioun, C.; Ribrag, Vincent; Thieblemont, C.; Unterhalt, Michael; Dreyling, Martin; Macintyre, E.; Pott, Christiane; Hermine, Olivier und Hoster, Eva
(2015):
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.
In: Blood, Bd. 126, Nr. 5: S. 604-611
Pastore, A.; Jurinovic, Vindi; Kridel, R.; Hoster, Eva; Staiger, A. M.; Szczepanowski, M.; Pott, Christiane; Kopp, N.; Murakami, M.; Horn, Heike; Leich, E.; Moccia, A. A.; Mottok, A.; Sunkavalli, A.; van Hummelen, P.; Ducar, M.; Ennishi, D.; Shulha, H. P.; Hother, C.; Connors, J. M.; Sehn, L. H.; Dreyling, Martin; Neuberg, D.; Moller, P.; Feller, A. C.; Hansmann, Martin-Leo; Stein, H.; Rosenwald, Andreas; Ott, German; Klapper, Wolfram; Unterhalt, Michael; Hiddemann, Wolfgang; Gascoyne, R. D.; Weinstock, D. M. und Weigert, O.
(2015):
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
In: Lancet Oncology, Bd. 16, Nr. 9: S. 1111-1122
Dreyling, Martin; Kluin-Nelemans, H. C.; Bea, Silvia; Klapper, Wolfram; Vogt, N.; Delfau-Larue, M. H.; Hutter, Grit; Cheah, C.; Chiappella, A.; Cortelazzo, Sergio; Pott, Christiane; Hess, G.; Visco, C.; Vitolo, U.; Klener, P.; Aurer, I.; Unterhalt, Michael; Ribrag, Vincent; Hoster, Eva und Hermine, Olivier
(2013):
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.
In: Leukemia & Lymphoma, Bd. 54, Nr. 4: S. 699-707
Metzner, B.; Müller, T. H.; Gebauer, W.; Casper, J.; Kraemer, D.; Rosien, B.; Schumann-Binarsch, S.; Thole, R.; Köhne, C. H.; Dreyling, Martin; Hoster, Eva und Pott, Christiane
(2013):
Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
In: Annals of Hematology, Bd. 93, Nr. 5: S. 803-810
Dreyling, Martin; Kluin-Nelemans, H. C.; Bea, Silvia; Hartmann, Elena; Salaverria, Itziar; Hutter, Grit; Perez-Galan, P.; Roue, G.; Pott, Christiane; Le Gouill, Steven; Cortelazzo, Sergio; Rule, S.; Hess, G.; Zaja, F.; Vitolo, U.; Szymczyk, Michal; Walewski, J.; Ribrag, Vincent; Unterhalt, Michael; Hermine, Olivier und Hoster, Eva
(2011):
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network.
In: Leukemia & Lymphoma, Bd. 52, Nr. 12: S. 2226-2236
Pott, Christiane; Hoster, Eva; Delfau-Larue, M. H.; Beldjord, K.; Böttcher, S.; Asnafi, V.; Plonquet, A.; Siebert, R.; Callet-Bauchu, E.; Andersen, N.; van Dongen, J. J.; Klapper, Wolfram; Berger, F.; Ribrag, Vincent; van Hoof, A. L.; Trneny, Marek; Walewski, J.; Dreger, P.; Unterhalt, Michael; Hiddemann, Wolfgang; Kneba, M.; Kluin-Nelemans, H. C.; Hermine, Olivier; Macintyre, E. und Dreyling, Martin
(2010):
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.
In: Blood, Bd. 115, Nr. 16: S. 3215-3223
Dreyling, Martin; Hoster, Eva; Bea, Silvia; Hartmann, Elena; Horn, Heike; Hutter, Grit; Salaverria, Itziar; Pott, Christiane; Trneny, Marek; Le Gouill, Steven; Cortelazzo, Sergio; Szymczyk, Michal; Jurczak, Wojciech; Shpilberg, Ofer; Ribrag, Vincent und Hermine, Olivier
(2010):
Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference.
In: Leukemia & Lymphoma, Bd. 51, Nr. 9: S. 1612-1622
Böttcher, S.; Ritgen, M.; Buske, S.; Gesk, S.; Klapper, Wolfram; Hoster, Eva; Hiddemann, Wolfgang; Unterhalt, Michael; Dreyling, Martin; Siebert, R.; Kneba, M. und Pott, Christiane
(2008):
Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
In: Haematologica, Bd. 93, Nr. 4: S. 551-559